This interview with Gregg Stone from Columbia University Medical Centre, New York, NY, USA discusses The Safety and Effectiveness as well as the Potential Short and Long-Term Benefits of Abbott Vascular Absorb™ Bioresorbable Vascular Scaffold (BVS) System, and the Absorb GT1™ BVS System (once commercially available), as Compared to the Commercially Approved, Control Stent XIENCE at TCT 2017.

Filmed by Radcliffe Cardiology on-site at TCT 2017.